临床表现 临床表现
David Facal1,2,3, Ana I Rodríguez-Pérez3,4,5, Fátima Fernández-Feijoo1,2
1Instituto de Psicoloxía (IPsiUS), Universidade de Santiago de Compostela, Santiago de Compostela, Galicia, Spain.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
认知虚弱 (CF) 与血阿尔茨海默病 (AD) 标志物有关,与没有认知衰退的身体虚弱 (PPF) 相比,在潜在可逆认知前虚弱 (PRCPF) 中发现的水平更高. 这表明认知状态在这些生物标志物方面比功能状态更有影响力.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
背景情况:
- 认知虚弱 (CF) 涉及同时出现的身体虚弱和认知障碍,不包括痴呆症.
- 肌痛性肌痛是潜在的可逆性,特别是在身体脆弱前期 (PPF) 和主观认知衰退 (SCD) 时.
- 虽然存在神经成像与CF的联系,但像NfL,Ab42,Ab40,t-Tau,p-tau181和p-tau217这样的血阿尔茨海默病 (AD) 生物标志物在这一背景下研究较少.
研究的目的:
- 研究血AD生物标志物与认知脆弱 (CF) 状态之间的关系.
- 为了比较不同脆弱性和认知状态中的特定血AD生物标志物的水平.
- 探索是否认知或功能状态与患有CF风险的个体的血AD生物标志物更强烈相关.
主要方法:
- 分析了325名参与者的血样本,使用超敏感的单分子阵列 (SIMOA) 技术.
- 含有NfL,Aβ-40,Aβ-42,tau,p-tau217和p-tau181.1.的量化度是什么
- 在非脆弱,没有认知衰退的PPF,RCPF和PRCPF组之间比较生物标志物水平.
主要成果:
- 在不同组之间观察到NfL和p-Tau217水平的显著差异.
- 与PRCPF组相比,在没有认知衰退的PPF组中发现了较低的NfL和p-Tau217水平.
- 这些发现表明,特定的血AD生物标志物与虚弱谱内的认知状态之间存在联系.
结论:
- 血AD生物标志物水平似乎与参与者的认知状态更密切相关,而不是他们的功能状态.
- 需要使用回归模型进行进一步的研究,以确认CF状态作为依赖变量,用血AD生物标志物和功能标志物作为预测因素.
- 这项研究强调了血生物标志物在理解和潜在地管理认知脆弱方面的潜在作用.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437


